Biosimilar Hyrimoz® (adalimumab) citrate-free high-concentration formulation (HCF) indicated for all conditions of reference medicine Humira®* Hyrimoz® HCF to launch progressively across Europe Hyrimoz® HCF strengthens well-established Sandoz biosimilar immunology portfolio in Europe Basel, November 21, 2023 – Sandoz, the global leader in generic and biosimilar medicines, today announces the launch

Collaboration between the International Center for Genetic Disease and the Department of Health – Abu Dhabi, advances state-of-the-art precision medicine approaches and techniques, tailoring prevention, diagnosis, and treatment of diseases for the Emirati population. This collaboration encompasses three strategic pillars: clinical and translational research, capacity building and technology transfer, and

Signs Memorandum of Understanding (MoU) with WadzPay to onboard world’s first cross-border private blockchain tokenization solution BPKH SELECTS WADZPAY’S UNIQUE BLOCKCHAIN-BASED PILGRIM PROGRAM TO CREATE CASHLESS JOURNEY FOR INDONESIA’S HAJJ AND UMRAH PILGRIMS PADANG, Indonesia, Nov. 20, 2023 (GLOBE NEWSWIRE) — WadzPay, a leading innovator in blockchain based payments technology,

Freshsales helps the company engage better with its business partners, improving sales conversion by 24% and Freshdesk boosts customer engagement up to 58% HONG KONG, Nov. 21, 2023 (GLOBE NEWSWIRE) — Freshworks Inc. (NASDAQ: FRSH), today announced that its customer Lalamove, the leading on-demand delivery platform in Hong Kong, uses

Year 2 Health Inclusivity Index Scores Phase two of Economist Impact’s Health Inclusivity Index, supported by Haleon, measures experience of health inclusion across 42,000 people in 40 countries Health inclusivity scores fall worldwide with addition of lived experience data, exposing glaring policy-practice gap in wealthy countries 66% of survey respondents